S2Medical AB (publ) (FRA:S21)

Germany flag Germany · Delayed Price · Currency is EUR
0.0003
+0.0001 (50.00%)
At close: Nov 28, 2025
-62.50%
Market Cap822.94K
Revenue (ttm)1.39M
Net Income (ttm)-247.47K
Shares Outn/a
EPS (ttm)-0.00
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volumen/a
Open0.0003
Previous Close0.0002
Day's Range0.0003 - 0.0003
52-Week Range0.0001 - 0.0085
Betan/a
RSI49.08
Earnings DateNov 18, 2025

About S2Medical AB

S2Medical AB (publ) develops products for wound healing, infection control, and cosmeceuticals spectrum in Sweden. The company offers odor eliminator under the YNOLENS brand; IvaQ, a negative pressure wound therapy (NPWT) system; Instagraft, a technology designed to make skin transplantation even in non-specialist healthcare setting; ADMERCIN, a solution against antibiotic-resistant bacteria; and Epiprotect, a technology designed to protect and support wound healing by creating an environment for tissue recovery. It also provides Symbiovance, a... [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 2013
Employees 7
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol S21
Full Company Profile

Financial Performance

Financial numbers in SEK Financial Statements

News

There is no news available yet.